EKF Diagnostics Holdings plc (EKDHF)
OTCMKTS · Delayed Price · Currency is USD
0.3516
-0.0014 (-0.40%)
At close: Jan 28, 2026
EKF Diagnostics Holdings Revenue
EKF Diagnostics Holdings had revenue of 25.24M GBP in the half year ending June 30, 2025, a decrease of -6.08%. This brings the company's revenue in the last twelve months to 50.22M, down -1.43% year-over-year. In the year 2024, EKF Diagnostics Holdings had annual revenue of 50.19M, down -4.59%.
Revenue (ttm)
50.22M GBP
Revenue Growth
-1.43%
P/S Ratio
2.05
Revenue / Employee
169.09K GBP
Employees
297
Market Cap
141.22M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.19M | -2.42M | -4.59% |
| Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
| Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
| Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
| Dec 31, 2020 | 65.26M | 20.34M | 45.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
EKF Diagnostics Holdings News
- 5 months ago - EKF Diagnostics Holdings plc (EKDHF) Q2 2025 Earnings Call Transcript - Seeking Alpha